PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsAutosomal dominant polycystic kidney
MeSH D016891 - autosomal dominant polycystic kidney
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D007690:Polycystic kidney diseases
0 Companies
0 Drugs
Success rate
D016891: 
Autosomal dominant polycystic kidney
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
OtsukaTolvaptan Jinarc  2015-05-27   
Clinical Trials
Historical Success Rate
Phase 1
67%
2/3
Phase 2
63%
10/16
Phase 3
31%
4/13
Approved: 1Overall Success rate: 13%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Otsuka
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use